EDAP TMS S.A. (FOCL) News
NASDAQ: FOCLHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
FOCL news summary
We found 3 recent headlines mentioning EDAP TMS S.A. (FOCL): 0 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. FOCL is making an outsized move today, down 7.45% at $2.61, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "FocalTherics Reports Lower Q3 Loss Of $4 Mln; Shares Drop 21% As Guidance Narrowed", was published by Nasdaq on Nov 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest EDAP TMS S.A. headlines
- FocalTherics Reports Lower Q3 Loss Of $4 Mln; Shares Drop 21% As Guidance Narrowed(RTTNews) - EDAP TMS S.A. or FocalTherics (FOCL), a robotic focal therapy company, recently announced financial results for the third quarter, noting a lower loss arising from increased sales.NasdaqFOCL, ET
- EDAP TMS (FOCL) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026Company to host conference call and webcast on Thursday, November 5 at 4:30 p.m. ET Company to host conference call and webcast on Thursday, November 5 at 4:30 p.m. ETGlobeNewswire